TM
NVAX icon

TigerOak Management’s Novavax NVAX Stock Holding History

TigerOak Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$86.6K Hold
10,640
– – 0.03% 126
2025
Q4 		$71.5K Hold
10,640
– – 0.02% 121
2025
Q3 		$92.2K Hold
10,640
– – 0.03% 117
2025
Q2 		$67K Hold
10,640
– – 0.02% 115
2025
Q1 		$68.2K Hold
10,640
– – 0.03% 107
2024
Q4 		$85.5K Buy
+10,640
New +$103K 0.03% 106

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TigerOak Management's NVAX Position: Q1 2026 in Review

TigerOak Management held its Novavax (NVAX) position steady in Q1 2026 at 10,640 shares worth $86.6K. The position accounts for 0.03% of the portfolio, ranked #126.

TigerOak Management first reported a position in NVAX in Q4 2024 and has held it in 6 quarters since. The position peaked at $92.2K in Q3 2025. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • TigerOak Management held 10,640 shares of Novavax worth $86.6K as of Q1 2026.
  • TigerOak Management left its Novavax share count unchanged in Q1 2026.
  • Novavax made up 0.03% of TigerOak Management's portfolio in Q1 2026, its #126 holding.
  • TigerOak Management first reported a position in Novavax in Q4 2024 and has held it in 6 quarters since.
  • TigerOak Management's Novavax position peaked at $92.2K in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on TigerOak Management's 13F filing for Q1 2026, filed 21 Apr 2026.